Showmenu

Pediatric Transplant Program | UC Davis Comprehensive Cancer Center

Pediatric Stem Cell Transplant and Cellular Therapy Program

We provide specialized care for children with complex conditions, including stem cell transplants, immune effector cell and gene therapies.

Pediatric nurse caring for a teenage patient in a hospital room

Pediatric Transplant and Cellular Therapy

The UC Davis Pediatric Stem Cell Transplant and Cellular Therapy Program provides advanced, life-saving care for children with complex and serious conditions — right here in the Sacramento region. Revitalized in 2023, the program reflects a renewed commitment to expanding access to cutting-edge therapies while delivering compassionate, family-centered care close to home.

Our program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), a recognition of our adherence to the highest national and international standards in stem cell transplantation and cellular therapy. We are also a fully approved California Children’s Services (CCS) Pediatric Bone Marrow Transplant Center, ensuring that children with the most complex medical needs can receive specialized care within our region, which includes stem cell transplants, immune effector cell therapy, and gene therapy.

Care and Collaboration

As a designated transplant center of the National Marrow Donor Program (NMDP), UC Davis patients have access to more than 22 million registered stem cell donors worldwide. This extensive network significantly expands donor options and helps ensure timely access to potentially life-saving transplants. Our program also participates in national clinical trials through cooperative groups offering patients access to innovative therapies and advancing the future of pediatric transplant care.

We offer a full range of transplant and cellular therapy options for children with:

  • High-risk leukemias and other blood cancers
  • Solid tumors such as neuroblastoma and medulloblastoma 
  • Hemoglobin disorders, such as sickle cell disease and thalassemia
  • Inherited metabolic disorders
  • Bone marrow failure syndromes
  • Primary immune deficiencies

As part of UC Davis Comprehensive Cancer Center, our pediatric program is closely integrated with the broader Stem Cell Transplant Program and the UC Davis Institute for Regenerative Cures. This collaboration brings together clinical expertise, innovative research, and access to emerging therapies — benefiting patients of all ages.

Families who come to UC Davis Health receive care from a dedicated, multidisciplinary team that supports each child at every stage — from diagnosis and transplant through recovery and long-term follow-up. As a regional leader in pediatric stem cell transplant and cellular therapy, we are committed to expanding access to advanced care while keeping children and families close to the support systems that matter most.

Our Team
  • Lisa Madden

    Assistant Professor

    View profile
  • Arun Ranjan Panigrahi, M.D.

    Associate Professor

    View profile
  • Nahal Lalefar, M.D.

    Nahal Lalefar, M.D.

    Assistant Professor

  • Kelly Yurkosky, RN

    Pediatric Stem Cell Transplant & Cellular Therapy Nurse Coordinator II

  • Courtney Erickson, RN

    Pediatric Stem Cell Transplant & Cellular Therapy Nurse Coordinator II

  • Amber Jewison, M.S., CPNP-AC

    Pediatric Hematology/Oncology/Cellular Therapy Inpatient Nurse Practitioner III

  • Nick Deuz, M.S.N., RN, CPNP-AC, CPHON, TCTCN

    Pediatric Hematology/Oncology/Cellular Therapy Inpatient Nurse Practitioner II

In the News
  • Pediatric Bone Marrow Transplant Program Now CCS-approved

    The UC Davis Health Pediatric Bone Marrow Transplant Program has earned official approval as a California Children’s Services (CCS) center, expanding local access to specialized, life-saving therapies for children with complex medical conditions.

    Read more
  • UC Davis Health Earns FACT Accreditation

    UC Davis Health’s adult and pediatric stem cell transplant programs have earned FACT accreditation, a global recognition of their adherence to the highest standards of quality and safety in cellular therapy and transplantation.

    Read more